Human chorionic gonadotropin (hCG) and intravenous immunoglobulin (IVIG) treatment were attempted as a novel therapeutic approach for unexplained recurrent spontaneous abortion (RSA). Forty-four and 3 women with a history of RSA were treated with
hCG
and IVIG, respectively, during pregnancy. Of these patients, serum blocking factor assay was performed before and after each treatment, in 15 patients; 12 cases with hCG and 3 cases with IVIG.
@ES The results were as follows:
@EN 1. Of 44 women who receive hCG during pregnancy, 24 delivered healthy infants at term, 10 patients suffered repeat abortion, and 10 women are still pregnant under 28 weeks. Over all success rate of hCG treatment was 70.6% (24/34). Although
there is
no statistical significance, absolute serm blocking level was decreased after treatment (N=12).
2. Of 3 women who receive IVIG during pregnancy, all 3 women are still pregnant under 28 weeks. Serum blocking level was increased after treatment, however, this increment was not statistically significant.
Although no conclusion could be extracted from the patients who received IVIG, the therapeutic effect of hCG is comparable to that of the other therapeutic regimens, such as allogeneic leukocytes. It was postulated that actual etiology of unknown
RSA
would be classified as hormonal origin although combined etiologies are common in Korean women.
|